Clinical trials
Phase 3 Clostridium Infections trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 2 |
| 2010 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2017 | 4 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Terminated | 4 |
| Recruiting | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Rebiotix Inc. | 2 |
| Seres Therapeutics, Inc. | 2 |
| Summit Therapeutics | 2 |
| Astellas Pharma Europe B.V. | 1 |
| Bausch Health Americas, Inc. | 1 |
| Bio-K Plus International Inc. | 1 |
| Finch Research and Development LLC. | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 1 |
| Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Clostridium Infections | 16 |
| Diarrhea | 6 |
| Communicable Diseases | 2 |
| Enterocolitis, Pseudomembranous | 2 |
| Infections | 2 |
| Digestive System Diseases | 1 |
| Dysentery | 1 |
| Gastrointestinal Diseases | 1 |
| Gram-Positive Bacterial Infections | 1 |
| Intestinal Diseases | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.